Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Other Working Capital Changes (2017 - 2025)

Historic Other Working Capital Changes for MediWound (MDWD) over the last 9 years, with Q3 2025 value amounting to -$23000.0.

  • MediWound's Other Working Capital Changes rose 7553.19% to -$23000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$53000.0, marking a year-over-year decrease of 1521.74%. This contributed to the annual value of -$30000.0 for FY2024, which is 13614.46% down from last year.
  • Latest data reveals that MediWound reported Other Working Capital Changes of -$23000.0 as of Q3 2025, which was up 7553.19% from $48000.0 recorded in Q2 2025.
  • In the past 5 years, MediWound's Other Working Capital Changes registered a high of $48000.0 during Q2 2025, and its lowest value of -$94000.0 during Q3 2024.
  • For the 5-year period, MediWound's Other Working Capital Changes averaged around $5142.9, with its median value being $9500.0 (2021).
  • The largest annual percentage gain for MediWound's Other Working Capital Changes in the last 5 years was 60000.0% (2021), contrasted with its biggest fall of 14761.9% (2021).
  • MediWound's Other Working Capital Changes (Quarter) stood at $10000.0 in 2021, then surged by 350.0% to $45000.0 in 2022, then crashed by 122.22% to -$10000.0 in 2023, then soared by 260.0% to $16000.0 in 2024, then crashed by 243.75% to -$23000.0 in 2025.
  • Its Other Working Capital Changes stands at -$23000.0 for Q3 2025, versus $48000.0 for Q2 2025 and $16000.0 for Q4 2024.